Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
- PMID: 35739328
- PMCID: PMC9225876
- DOI: 10.1007/s00520-022-07103-5
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
Figures

Similar articles
-
Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection.Curr Opin Hematol. 1997 May;4(3):200-6. doi: 10.1097/00062752-199704030-00008. Curr Opin Hematol. 1997. PMID: 9209837 Review.
-
[Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].Di Yi Jun Yi Da Xue Xue Bao. 2004 Sep;24(9):1051-2. Di Yi Jun Yi Da Xue Xue Bao. 2004. PMID: 15447861 Chinese.
-
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19. J Infect Dis. 2002. PMID: 11992286 Review.
-
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.Crit Care. 2011;15(1):R58. doi: 10.1186/cc10031. Epub 2011 Feb 10. Crit Care. 2011. PMID: 21310070 Free PMC article. Review.
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857. J Infect Dis. 1999. PMID: 10081506 Review.
Cited by
-
Effects of prime-boost strategies on the protective efficacy and immunogenicity of a PLGA (85:15)-encapsulated Chlamydia recombinant MOMP nanovaccine.Pathog Dis. 2024 Feb 7;82:ftae004. doi: 10.1093/femspd/ftae004. Pathog Dis. 2024. PMID: 38862192 Free PMC article.
-
Comorbidities and Angiogenic Regulators Affect Endothelial Progenitor Cell Subtype Numbers in a Healthy Volunteer Control Group.Stem Cell Rev Rep. 2024 Nov;20(8):2336-2344. doi: 10.1007/s12015-024-10777-5. Epub 2024 Aug 26. Stem Cell Rev Rep. 2024. PMID: 39186241 Free PMC article.
-
Growth Factor in the Setting of CAR T-Cell Therapy: To Use or Not to Use.J Adv Pract Oncol. 2024 May;15(4):253-264. doi: 10.6004/jadpro.2024.15.4.3. Epub 2024 May 1. J Adv Pract Oncol. 2024. PMID: 39301101 Free PMC article. Review.
-
Interplay of Oxidative Stress, Inflammation, and Autophagy in RAW 264.7 Murine Macrophage Cell Line Challenged with Si/SiO2 Quantum Dots.Materials (Basel). 2023 Jul 19;16(14):5083. doi: 10.3390/ma16145083. Materials (Basel). 2023. PMID: 37512357 Free PMC article.
-
The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients.Cureus. 2023 Sep 28;15(9):e46105. doi: 10.7759/cureus.46105. eCollection 2023 Sep. Cureus. 2023. PMID: 37779681 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources